Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome

Ann Rheum Dis. 2008 Feb;67(2):278-9. doi: 10.1136/ard.2006.068254.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Dermatologic Agents / therapeutic use*
  • Female
  • Humans
  • Interleukin 1 Receptor Antagonist Protein / therapeutic use*
  • Middle Aged
  • Receptors, Interleukin-1 / therapeutic use
  • Sweet Syndrome / drug therapy*
  • Treatment Outcome

Substances

  • Dermatologic Agents
  • Interleukin 1 Receptor Antagonist Protein
  • Receptors, Interleukin-1